Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

Genetic Variants of CYP2D6 Gene and Cancer Risk: A HuGE Systematic Review and Meta-analysis

(2013) Li-Ping Zhou et al.   Asian Pacific Journal of Cancer Prevention

A Clinical Tool for Reducing Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk

(2013) Lauren E. Kelly et al.   PLoS One

More Codeine Fatalities After Tonsillectomy in North American Children

(2012) L. E. Kelly et al.   PEDIATRICS

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

(2011) K R Crews et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study

(2011) Trine Naalsund Andreassen et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

CYP2D6and the severity of suicide attempts

(2011) Eva M Peñas-Lledó et al.   PHARMACOGENOMICS

Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs

(2011) Donna A. Volpe et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone

(2010) CF Samer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

(2010) Silvana Borges et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance

(2010) Karel Allegaert et al.   PEDIATRIC ANESTHESIA

Impact of theCYP2D6genotype on post-operative intravenous oxycodone analgesia

(2009) S. T. ZWISLER et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

The Hypoalgesic Effect of Oxycodone in Human Experimental Pain Models in Relation to the CYP2D6 Oxidation Polymorphism

(2009) Stine T. Zwisler et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Risk to the Breast-Fed Neonate From Codeine Treatment to the Mother: A Quantitative Mechanistic Modeling Study

(2009) S Willmann et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effects of the CYP2D6 Gene Duplication on the Pharmacokinetics and Pharmacodynamics of Tramadol

(2009) Julia Kirchheiner et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death

(2009) Catherine Ciszkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?

(2009) Jörn Lötsch et al.   PAIN

Codeine and morphine pathway

(2009) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study

(2008) P Madadi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Developmental Changes in Human Liver CYP2D6 Expression

(2008) J. C. Stevens et al.   DRUG METABOLISM AND DISPOSITION

Pharmacogenetics of analgesics: toward the individualization of prescription

(2008) Victoria Rollason et al.   PHARMACOGENOMICS